Atypical Withdrawal Symptoms after Abrupt Tramadol Discontinuation: A Case Report.


Journal

Journal of pain & palliative care pharmacotherapy
ISSN: 1536-0539
Titre abrégé: J Pain Palliat Care Pharmacother
Pays: England
ID NLM: 101125608

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 29 11 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: ppublish

Résumé

Tramadol is a commonly utilized analgesic in the United States. One common misconception is that tramadol is safer than other opioid medications, or less likely to cause physical dependence. Given these misconceptions, the likelihood of patients experiencing withdrawal after discontinuation may be commonly overlooked as well. A 68-year old female patient with fibromyalgia was referred to a clinical pharmacy pain clinic for medication management. The patient was evaluated one month after abrupt discontinuation of tramadol 50 mg every 6 h for at least 10 years of use. She reports concerning symptoms of significant mucus production, fullness in chest and soreness in neck. Although tramadol is a Schedule IV Controlled Substance the risk of physical dependence and likelihood of patients experiencing withdrawal symptoms after abrupt cessation should not be diminished. Tramadol should not be considered a "safer" opioid therapy without potential of classic or atypical withdrawal symptoms, as well as risk of abuse, misuse or addiction.

Identifiants

pubmed: 37791819
doi: 10.1080/15360288.2023.2261913
doi:

Substances chimiques

Tramadol 39J1LGJ30J
Analgesics, Opioid 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-323

Auteurs

Caylee Sams (C)

Pharmacy Department, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, USA.

Serena Cheng (S)

Pharmacy Department, VA San Diego Health Care System, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH